Cleared Traditional

K213971 - Atrial Fibrillation History Feature
(FDA 510(k) Clearance)

Jun 2022
Decision
165d
Days
Class 2
Risk

K213971 is an FDA 510(k) clearance for the Atrial Fibrillation History Feature. This device is classified as a Photoplethysmograph Analysis Software For Over-the-counter Use (Class II - Special Controls, product code QDB).

Submitted by Apple, Inc. (Cupertino, US). The FDA issued a Cleared decision on June 3, 2022, 165 days after receiving the submission on December 20, 2021.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2790. A Photoplethysmograph Analysis Software Device For Over-the-counter Use Analyzes Photoplethysmograph Data And Provides Information For Identifying Irregular Heart Rhythms. This Device Is Not Intended To Provide A Diagnosis..

Submission Details

510(k) Number K213971 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2021
Decision Date June 03, 2022
Days to Decision 165 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code QDB — Photoplethysmograph Analysis Software For Over-the-counter Use
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2790
Definition A Photoplethysmograph Analysis Software Device For Over-the-counter Use Analyzes Photoplethysmograph Data And Provides Information For Identifying Irregular Heart Rhythms. This Device Is Not Intended To Provide A Diagnosis.